Trisha Suppes, MD, PhD

Psychiatrist

Professor of Psychiatry and Behavioral Sciences

Professional Education

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1992)

Fellowship: Mclean Hospital (06/01/1992) MA

Residency: Mclean Hospital (06/01/1991) MA

Medical Education: Dartmouth Medical School (06/01/1987) NH

Fellowship, Harvard Medical School, Neuroscience (1992)

Fellowship, Harvard Medical School, Psychiatry (1992)

M.D., Dartmouth, Medicine (1987)

Fellowship, Stanford University, Neuroscience (1983)

Ph.D., UCLA, Anatomy and Physiology (1980)

Honors & Awards

Elected to Fellow, American College of Neuropsychopharmacology (ACNP) (2009)

Elected as a member, American College of Psychiatrists (2013)

Elected by peers for inclusion, Best Doctors in America® (1996-2010)

Councilor, Board of Councilors, International Society for Bipolar Disorders (ISBD) (2009-2011)

Gerald L. Klerman Senior Investigator Award, Depression and Bipolar Support Alliance (2008)

Administrative Appointments

Member, Editorial Board, International Journal of Bipolar Disorders (2009 - Present)

Associate Editor, American Journal of Psychiatry (2009 - Present)

Director, Center for Clinical Research, VA Palo Alto Health Care System, Palo Alto, CA (2013 - Present)

Director, Cooperative Studies Program (CSP) Network of Dedicated Enrollment Sites (NODES), VA Palo Alto (2012 - Present)

Director, Bipolar and Depression Research Program, VA Palo Alto Health Care System, Palo Alto, CA (2008 - Present)

Chair for Veterans Affairs, Department of Defense and VA Bipolar Disorder Treatment Guidelines (2008 - Present)

Member, Sub Workgroup for Mood Disorders, American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders 5 (DSM5) (2007 - 2012)

Member, Workgroup for Mood Disorders, American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders 5 (DSM5) (2007 - 2012)

Member, American Psychiatric Association Work Group for the Practice Guidelines for Bipolar Disorder (2006 - 2009)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone Monotherapy in Bipolar Disorder With Co-Occurring Lifetime Panic or Generalized Anxiety Disorder
Suppes, T., McElroy, S. L., Sheehan, D. V., Hidalgo, R. B., Cosgrove, V. E., & Feldman, N. S. (2014). A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone Monotherapy in Bipolar Disorder With Co-Occurring Lifetime Panic or Generalized Anxiety Disorder. JOURNAL OF CLINICAL PSYCHIATRY, 75(1), 77-84.

More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany
Post, R. M., Altshuler, L., Leverich, G., Nolen, W., Kupka, R., & Rowe, M. (2013). More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany. PSYCHIATRY RESEARCH, 210(3), 880-886.

MAINTENANCE TREATMENT WITH QUETIAPINE WHEN COMBINED WITH EITHER LITHIUM OR DIVALPROEX IN BIPOLAR I DISORDER: ANALYSIS OF TWO LARGE RANDOMIZED, PLACEBO-CONTROLLED TRIALS
Suppes, T., Vieta, E., Gustafsson, U., & Ekholm, B. (2013). MAINTENANCE TREATMENT WITH QUETIAPINE WHEN COMBINED WITH EITHER LITHIUM OR DIVALPROEX IN BIPOLAR I DISORDER: ANALYSIS OF TWO LARGE RANDOMIZED, PLACEBO-CONTROLLED TRIALS. DEPRESSION AND ANXIETY, 30(11), 1089-1098.

Presentation and prevalence of PTSD in a bipolar disorder population: A STEP-BD examination
Hernandez, J. M., Cordova, M. J., Ruzek, J., Reiser, R., Gwizdowski, I. S., & Ostacher, M. J. (2013). Presentation and prevalence of PTSD in a bipolar disorder population: A STEP-BD examination. JOURNAL OF AFFECTIVE DISORDERS, 150(2), 450-455.

First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo
Suppes, T., Ketter, T. A., Gwizdowski, I. S., Dennehy, E. B., Hill, S. J., & Cosgrove, V. E. (2013). First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo. JOURNAL OF AFFECTIVE DISORDERS, 150(1), 37-43.

Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder
Gonzalez, R., Tamminga, C., Tohen, M., & Suppes, T. (2013). Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 149(1-3), 363-366.

Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder
Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Suppes, T., & Rowe, M. (2013). Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 147(1-3), 288-294.

Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder
Seo, J. S., Jamieson, K., Cosgrove, V., Gwizdowski, I. S., Yang, H., & Suppes, T. (2013). Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder. EUROPEAN PSYCHIATRY, 28(3), 190-196.

Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient
Sheehan, D. V., Harnett-Sheehan, K., Hidalgo, R. B., Janavs, J., McElroy, S. L., & Suppes, T. (2013). Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. JOURNAL OF AFFECTIVE DISORDERS, 145(1), 83-94.

Multivariate analysis of bipolar mania: Retrospectively assessed structure of bipolar I manic and mixed episodes in randomized clinical trial participants
Swann, A. C., Suppes, T., Ostacher, M. J., Eudicone, J. M., McQuade, R., & Carlson, B. X. (2013). Multivariate analysis of bipolar mania: Retrospectively assessed structure of bipolar I manic and mixed episodes in randomized clinical trial participants. JOURNAL OF AFFECTIVE DISORDERS, 144(1-2), 59-64.

Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia.
Cosgrove, V. E., & Suppes, T. (2013). Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia. BMC medicine, 11, 127-?.

Bipolar Mixed States: An International Society for Bipolar Disorders Task Force Report of Symptom Structure, Course of Illness, and Diagnosis
Swann, A. C., Lafer, B., Perugi, G., Frye, M. A., Bauer, M., & Suppes, T. (2013). Bipolar Mixed States: An International Society for Bipolar Disorders Task Force Report of Symptom Structure, Course of Illness, and Diagnosis. AMERICAN JOURNAL OF PSYCHIATRY, 170(1), 31-42.

Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder
Vieta, E., Suppes, T., Ekholm, B., Udd, M., & Gustafsson, U. (2012). Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder. JOURNAL OF AFFECTIVE DISORDERS, 142(1-3), 36-44.

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients
Post, R. M., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., & Goodwin, F. K. (2012). Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients. JOURNAL OF CLINICAL PSYCHIATRY, 73(7), 924-930.

Co-occurrence of Serious or Undiagnosed Medical Conditions With Bipolar Disorder Preventing Clinical Trial Randomization: A Case Series
Feldman, N. S., Gwizdowski, I. S., Fischer, E. G., Yang, H., & Suppes, T. (2012). Co-occurrence of Serious or Undiagnosed Medical Conditions With Bipolar Disorder Preventing Clinical Trial Randomization: A Case Series. JOURNAL OF CLINICAL PSYCHIATRY, 73(6), 874-877.

Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany
Post, R. M., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., & Rowe, M. (2011). Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 26(2), 96-106.

Prevalence and correlates of eating disorders in 875 patients with bipolar disorder
McElroy, S. L., Frye, M. A., Hellemann, G., Altshuler, L., Leverich, G. S., & Post, R. M. (2011). Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 128(3), 191-198.

Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder
Kupfer, D. J., Angst, J., Berk, M., Dickerson, F., Frangou, S., & Zarate, C. A. (2011). Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder. ANNALS MEETING REPORTS, 1242, 1-25.

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder
Post, R. M., Altshuler, L. L., Frye, M. A., Suppes, T., Keck, P. E., & Nolen, W. A. (2010). Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder. JOURNAL OF CLINICAL PSYCHIATRY, 71(9), 1176-1186.

Early-Onset Bipolar Disorder and Treatment Delay Are Risk Factors for Poor Outcome in Adulthood
Post, R. M., Leverich, G. S., Kupka, R. W., Keck, P. E., McElroy, S. L., & Nolen, W. A. (2010). Early-Onset Bipolar Disorder and Treatment Delay Are Risk Factors for Poor Outcome in Adulthood. JOURNAL OF CLINICAL PSYCHIATRY, 71(7), 864-872.

Is There a Role for Antidepressants in the Treatment of Bipolar II Depression?
Suppes, T. (2010). Is There a Role for Antidepressants in the Treatment of Bipolar II Depression?. AMERICAN JOURNAL OF PSYCHIATRY, 167(7), 738-740.

Gender and Depressive Symptoms in 711 Patients With Bipolar Disorder Evaluated Prospectively in the Stanley Foundation Bipolar Treatment Outcome Network
Altshuler, L. L., Kupka, R. W., Hellemann, G., Frye, M. A., Sugar, C. A., & Zermeno, M. (2010). Gender and Depressive Symptoms in 711 Patients With Bipolar Disorder Evaluated Prospectively in the Stanley Foundation Bipolar Treatment Outcome Network. AMERICAN JOURNAL OF PSYCHIATRY, 167(6), 708-715.

The Quick Inventory of Depressive Symptomatology (Clinician and Self-Report Versions) in Patients With Bipolar Disorder
Bernstein, I. H., Rush, A. J., Suppes, T., Kyotoku, Y., & Warden, D. (2010). The Quick Inventory of Depressive Symptomatology (Clinician and Self-Report Versions) in Patients With Bipolar Disorder. CNS SPECTRUMS, 15(6), 367-373.

Genetics and intermediate phenotypes of the schizophrenia bipolar disorder boundary
Ivleva, E. I., Morris, D. W., Moates, A. F., Suppes, T., Thaker, G. K., & Tamminga, C. A. (2010). Genetics and intermediate phenotypes of the schizophrenia bipolar disorder boundary. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 34(6), 897-921.

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
Suppes, T., Datto, C., Minkwitz, M., Nordenhem, A., Walker, C., & Darko, D. (2010). Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. JOURNAL OF AFFECTIVE DISORDERS, 121(1-2), 106-115.

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo
Goldberg, J. F., Calabrese, J. R., Saville, B. R., Frye, M. A., Ketter, T. A., & Goodwin, F. K. (2009). Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo. JOURNAL OF CLINICAL PSYCHIATRY, 70(9), 1273-1280.

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
Tohen, M., Frank, E., Bowden, C. L., Colom, F., Ghaemi, S. N., & Berk, M. (2009). The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. BIPOLAR DISORDERS, 11(5), 453-473.

Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
Frye, M. A., Yatham, L., Ketter, T. A., Goldberg, J., Suppes, T., & Adams, B. (2009). Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies. ACTA PSYCHIATRICA SCANDINAVICA, 120(1), 10-13.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety
Sheehan, D. V., McElroy, S. L., Harnett-Sheehan, K., Keck, P. E., Janavs, J., & Suppes, T. (2009). Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. JOURNAL OF AFFECTIVE DISORDERS, 115(3), 376-385.

A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C-16) in patients with bipolar disorder
Bernstein, I. H., Rush, A. J., Suppes, T., Trivedi, M. H., Woo, A., & Carmody, T. J. (2009). A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C-16) in patients with bipolar disorder. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 18(2), 138-146.

The Safety, Acceptability, and Effectiveness of Acupuncture as an Adjunctive Treatment for Acute Symptoms in Bipolar Disorder
Dennehy, E. B., Schnyer, R., Bernstein, I. H., Gonzalez, R., Shivakumar, G., & Suppes, T. (2009). The Safety, Acceptability, and Effectiveness of Acupuncture as an Adjunctive Treatment for Acute Symptoms in Bipolar Disorder. JOURNAL OF CLINICAL PSYCHIATRY, 70(6), 897-905.

Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127)
Suppes, T., Vieta, E., Liu, S., Brecher, M., & Paulsson, B. (2009). Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127). AMERICAN JOURNAL OF PSYCHIATRY, 166(4), 476-488.

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study
Altshuler, L. L., Post, R. M., Hellemann, G., Leverich, G. S., Nolen, W. A., & Suppes, T. (2009). Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study. JOURNAL OF CLINICAL PSYCHIATRY, 70(4), 450-457.

Correlates of Treatment-Emergent Mania Associated With Antidepressant Treatment in Bipolar Depression
Frye, M. A., Helleman, G., McElroy, S. L., Altshuler, L. L., Black, D. O., & Suppes, T. (2009). Correlates of Treatment-Emergent Mania Associated With Antidepressant Treatment in Bipolar Depression. AMERICAN JOURNAL OF PSYCHIATRY, 166(2), 164-172.

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression
Suppes, T., Marangell, L. B., Bernstein, I. H., Kelly, D. I., Fischer, E. G., & Gonzalez, R. (2008). A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. JOURNAL OF AFFECTIVE DISORDERS, 111(2-3), 334-343.

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)
Vieta, E., Suppes, T., Eggens, I., Persson, I., Paulsson, B., & Brecher, M. (2008). Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). JOURNAL OF AFFECTIVE DISORDERS, 109(3), 251-263.

Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: A post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies
Weisler, R. H., Calabrese, J. R., Thase, M. E., Arvekvist, R., Stening, G., & Suppes, T. (2008). Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: A post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. JOURNAL OF CLINICAL PSYCHIATRY, 69(5), 769-782.

Awareness of metabolic concerns in patients with bipolar disorder: A survey of European psychiatrists
Bauer, M., Lecrubier, Y., & Suppes, T. (2008). Awareness of metabolic concerns in patients with bipolar disorder: A survey of European psychiatrists. EUROPEAN PSYCHIATRY, 23(3), 169-177.

Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder
Suppes, T., Eudicone, J., McQuade, R., Pikalov, A., & Carlson, B. (2008). Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. JOURNAL OF AFFECTIVE DISORDERS, 107(1-3), 145-154.

Are bipolar mood symptoms affected by the phase of the menstrual cycle?
Shivakumar, G., Bernstein, I. H., & Suppes, T. (2008). Are bipolar mood symptoms affected by the phase of the menstrual cycle?. JOURNAL OF WOMENS HEALTH, 17(3), 473-478.

Incidence of childhood-onset bipolar illness in the USA and Europe
Post, R. M., Luckenbaugh, D. A., Leverich, G. S., Altshuler, L. L., Frye, M. A., & Walden, J. (2008). Incidence of childhood-onset bipolar illness in the USA and Europe. BRITISH JOURNAL OF PSYCHIATRY, 192(2), 150-151.

A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder
Marangell, L. B., Suppes, T., Zboyan, H. A., Prashad, S. J., Fischer, G., & Allen, J. C. (2008). A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. JOURNAL OF CLINICAL PSYCHIATRY, 69(2), 183-189.

Bipolar II disorder: arguments for and against a distinct diagnostic entity
Vieta, E., & Suppes, T. (2008). Bipolar II disorder: arguments for and against a distinct diagnostic entity. BIPOLAR DISORDERS, 10(1), 163-178.

An investigation of water lithium concentrations and rates of violent acts in 11 texas counties: Can an association be easily shown?
Gonzalez, R., Bernstein, I., & Suppes, T. (2008). An investigation of water lithium concentrations and rates of violent acts in 11 texas counties: Can an association be easily shown?. JOURNAL OF CLINICAL PSYCHIATRY, 69(2), 325-326.

Awareness of the metabolic syndrome in patients with bipolar disorder: A comparison of US and European psychiatrists
Lecrubier, Y., Bauer, M., Hirschfeld, R., McElroy, S., & Suppes, T. (2008). Awareness of the metabolic syndrome in patients with bipolar disorder: A comparison of US and European psychiatrists. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 12(3), 187-195.

Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies
Suppes, T., Hirschfeld, R. M., Vieta, E., Raines, S., & Paulsson, B. (2008). Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 9(3), 198-211.

Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder
Goldberg, J. F., Bowden, C. L., Calabrese, J. R., Ketter, T. A., Dann, R. S., & Post, R. M. (2008). Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. BIOLOGICAL PSYCHIATRY, 63(1), 125-130.

Clinical implications of anti psychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders - Recent developments and current perspectives
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007). Clinical implications of anti psychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders - Recent developments and current perspectives. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 27(6), 639-661.

Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network
Suppes, T., Kelly, D. I., Keck, P. E., McElroy, S. L., Altshuler, L. L., & Grunze, H. (2007). Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 22(6), 376-381.

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder
Kupka, R. W., Altshuler, L. L., Nolen, W. A., Suppes, T., Luckenbaugh, D. A., & Post, R. M. (2007). Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. BIPOLAR DISORDERS, 9(5), 531-535.

Open-label aripiprazole in the treatment of acute bipolar depression: A prospective pilot trial
McElroy, S. L., Suppes, T., Frye, M. A., Altshuler, L. L., Stanford, K., & Keck, P. E. (2007). Open-label aripiprazole in the treatment of acute bipolar depression: A prospective pilot trial. JOURNAL OF AFFECTIVE DISORDERS, 101(1-3), 275-281.

Alcoholism and anxiety in bipolar illness: Differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism
Levander, E., Frye, M. A., McElroy, S., Suppes, T., Grunze, H., & Post, R. M. (2007). Alcoholism and anxiety in bipolar illness: Differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. JOURNAL OF AFFECTIVE DISORDERS, 101(1-3), 211-217.

A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression
Frye, M. A., Grunze, H., Suppes, T., McElroy, S. L., Keck, P. E., & Post, R. M. (2007). A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. AMERICAN JOURNAL OF PSYCHIATRY, 164(8), 1242-1249.

Dimensions and the psychosis phenotype
Allardyce, J., Suppes, T., & van Os, J. (2007). Dimensions and the psychosis phenotype. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 16, S34-S40.

A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders
McElroy, S. L., Frye, M. A., Altshuler, L. L., Suppes, T., Hellemann, G., & Keck, P. E. (2007). A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. BIPOLAR DISORDERS, 9(4), 426-434.

Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study
Nolen, W. A., Kupka, R. W., Hellemann, G., Frye, M. A., Altshuler, L. L., & Post, R. M. (2007). Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. ACTA PSYCHIATRICA SCANDINAVICA, 115(5), 360-365.

The poor prognosis of childhood-onset bipolar disorder
Leverich, G. S., Post, R. M., Keck, P. E., Altshuler, L. L., Frye, M. A., & Luckenbaugh, D. (2007). The poor prognosis of childhood-onset bipolar disorder. JOURNAL OF PEDIATRICS, 150(5), 485-490.

Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder
Suppes, T., Kelly, D. I., Hlynan, L. S., Snow, D. E., Sureddi, S., & Curley, E. (2007). Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 41(5), 397-402.

Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists
Suppes, T., McElroy, S. L., & Hirschfeld, R. (2007). Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists. PSYCHOPHARMACOLOGY BULLETIN, 40(2), 22-37.

Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report
Joffe, H., Cohen, L. S., Suppes, T., Hwang, C. H., Molay, F., & Hall, J. E. (2006). Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report. BIOLOGICAL PSYCHIATRY, 60(12), 1378-1381.

New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.
Post, R. M., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S., & Grunze, H. (2006). New findings from the Bipolar Collaborative Network: clinical implications for therapeutics. Current psychiatry reports, 8(6), 489-497.

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder
Keck, P. E., Mintz, J., McElroy, S. L., Freeman, M. P., Frye, T. S. M. A., & Post, R. M. (2006). Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. BIOLOGICAL PSYCHIATRY, 60(9), 1020-1022.

Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: An evaluation of 2 placebo-controlled maintenance trials
Frye, M. A., Yatham, L. N., Calabrese, J. R., Bowden, C. L., Ketter, T. A., & Thompson, T. R. (2006). Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: An evaluation of 2 placebo-controlled maintenance trials. JOURNAL OF CLINICAL PSYCHIATRY, 67(11), 1721-1728.

Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: Results of a large, multisite study
Altshuler, L. L., Post, R. M., Black, D. O., Keck, P. E., Nolen, W. A., & Mintz, J. (2006). Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: Results of a large, multisite study. JOURNAL OF CLINICAL PSYCHIATRY, 67(10), 1551-1560.

Omega-3 fatty acids in bipolar disorder: Clinical and research considerations
Marangell, L. B., Suppes, T., Ketter, T. A., Dennehy, E. B., Zboyan, H., & Sachs, G. (2006). Omega-3 fatty acids in bipolar disorder: Clinical and research considerations. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 75(4-5), 315-321.

Implementation of the texas medication algorithm project patient and family education program
Toprac, M. G., Dennehy, E. B., Carmody, T. J., Crismon, M. L., Miller, A. L., & Rush, A. J. (2006). Implementation of the texas medication algorithm project patient and family education program. JOURNAL OF CLINICAL PSYCHIATRY, 67(9), 1362-1372.

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline
Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Nolen, W. A., & Mintz, J. (2006). Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. BRITISH JOURNAL OF PSYCHIATRY, 189, 124-131.

Recurrence in bipolar I disorder: A post hoc analysis excluding relapses in two double-blind maintenance studies
Calabrese, J. R., Goldberg, J. F., Ketter, T. A., Suppes, T., Frye, M., & Thompson, T. R. (2006). Recurrence in bipolar I disorder: A post hoc analysis excluding relapses in two double-blind maintenance studies. BIOLOGICAL PSYCHIATRY, 59(11), 1061-1064.

Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder
Joffe, H., Cohen, L. S., Suppes, T., McLaughlin, W. L., Lavori, P., & Sachs, G. S. (2006). Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. BIOLOGICAL PSYCHIATRY, 59(11), 1078-1086.

An empirical analysis of cost outcomes of the Texas medication algorithm project
Kashner, T. M., Rush, A. J., Crismon, M. L., Toprac, M., Carmody, T. J., & Suppes, T. (2006). An empirical analysis of cost outcomes of the Texas medication algorithm project. PSYCHIATRIC SERVICES, 57(5), 648-659.

Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants
Altshuler, L. L., Suppes, T., Black, D. O., Nolen, W. A., Leverich, G., & Post, R. (2006). Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. AMERICAN JOURNAL OF PSYCHIATRY, 163(2), 313-315.

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and Bupropion as adjuncts to mood stabilizers
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., & Post, R. M. (2006). Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and Bupropion as adjuncts to mood stabilizers. AMERICAN JOURNAL OF PSYCHIATRY, 163(2), 232-239.

Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project
Dennehy, E. B., Suppes, T., Rush, A. J., Miller, A. L., Trivedi, M. H., & Kashner, T. M. (2005). Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. PSYCHOLOGICAL MEDICINE, 35(12), 1695-1706.

Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: Post hoc analyses of 47-week data
Suppes, T., Brown, E., Schuh, L. M., Baker, R. W., & Tohen, M. (2005). Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: Post hoc analyses of 47-week data. JOURNAL OF AFFECTIVE DISORDERS, 89(1-3), 69-77.

Quality of care measures for the treatment of bipolar disorder
Duffy, F. F., Narrow, W., West, J. C., Fochtmann, L. J., Kahn, D. A., & Regier, D. (2005). Quality of care measures for the treatment of bipolar disorder. PSYCHIATRIC QUARTERLY, 76(3), 213-230.

Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network - A sex-specific phenomenon
Suppes, T., Mintz, J., McElroy, S. L., Altshuler, L. L., Kupka, R. W., & Post, R. M. (2005). Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network - A sex-specific phenomenon. ARCHIVES OF GENERAL PSYCHIATRY, 62(10), 1089-1096.

Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients
Kupka, R. W., Luckenbaugh, D. A., Post, R. M., Suppes, T., Altshuler, L. L., & Nolen, W. A. (2005). Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. AMERICAN JOURNAL OF PSYCHIATRY, 162(7), 1273-1280.

The Texas Implementation of Medication Algorithms: Update to the algorithms for treatment of bipolar I disorder
Suppes, T., Dennehy, E. B., Hirschfeld, R. Ma., Altshuler, L. L., Bowden, C. L., & Swann, A. C. (2005). The Texas Implementation of Medication Algorithms: Update to the algorithms for treatment of bipolar I disorder. JOURNAL OF CLINICAL PSYCHIATRY, 66(7), 870-886.

Brief Psychiatric Rating Scale Expanded Version: How do new items affect factor structure?
Velligan, D., Prihoda, T., Dennehy, E., Biggs, M., Shores-Wilson, K., & Shon, S. (2005). Brief Psychiatric Rating Scale Expanded Version: How do new items affect factor structure?. PSYCHIATRY RESEARCH, 135(3), 217-228.

Reproductive function and risk for PCOS in women treated for bipolar disorder
Rasgon, N. L., Altshuler, L. L., Fairbanks, L., Elman, S., Bitran, J., & Mintz, J. (2005). Reproductive function and risk for PCOS in women treated for bipolar disorder. BIPOLAR DISORDERS, 7(3), 246-259.

Open-label adjunctive zonisamide in the treatment of bipolar disorders: A prospective trial
McElroy, S. L., Suppes, T., Keck, P. E., Black, D., Frye, M. A., & Post, R. M. (2005). Open-label adjunctive zonisamide in the treatment of bipolar disorders: A prospective trial. JOURNAL OF CLINICAL PSYCHIATRY, 66(5), 617-624.

The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence
Golden, R. N., Gaynes, B. N., Ekstrom, R. D., Hamer, R. M., JACOBSEN, F. M., & Nemeroff, C. B. (2005). The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence. AMERICAN JOURNAL OF PSYCHIATRY, 162(4), 656-662.

Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder
Post, R. M., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., & Grunze, H. (2005). Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. JOURNAL OF CLINICAL PSYCHIATRY, 66(3), 370-374.

Low doses of clozapine may stabilize treatment-resistant bipolar patients
Fehr, B. S., Ozcan, M. E., & Suppes, T. (2005). Low doses of clozapine may stabilize treatment-resistant bipolar patients. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 255(1), 10-14.

Challenges in the management of bipolar depression
Suppes, T., Kelly, D. I., & Perla, J. M. (2005). Challenges in the management of bipolar depression. JOURNAL OF CLINICAL PSYCHIATRY, 66, 11-16.

Atypical antipsychotics in bipolar depression: Potential mechanisms of action
Yatham, L. N., Goldstein, J. M., Vieta, E., Bowden, C. L., Grunze, H., & Calabrese, J. R. (2005). Atypical antipsychotics in bipolar depression: Potential mechanisms of action. JOURNAL OF CLINICAL PSYCHIATRY, 66, 40-48.

A cautionary note when using zonisamide in youths a case report of association with toxic epidermal necrolysis
Majeres, K. D., & Suppes, T. (2004). A cautionary note when using zonisamide in youths a case report of association with toxic epidermal necrolysis. JOURNAL OF CLINICAL PSYCHIATRY, 65(12), 1720-1720.

Effects of clozapine on sleep in bipolar and schizoaffective disorders
Armitage, R., Cole, D., Suppes, T., & Ozcan, M. E. (2004). Effects of clozapine on sleep in bipolar and schizoaffective disorders. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 28(7), 1065-1070.

Treatment of bipolar mania with atypical antipsychotics.
Chengappa, K. Nr., Suppes, T., & Berk, M. (2004). Treatment of bipolar mania with atypical antipsychotics. Expert review of neurotherapeutics, 4(6), S17-25.

Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation
Carlson, P. J., Merlock, M. C., & Suppes, T. (2004). Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. BIPOLAR DISORDERS, 6(5), 416-420.

Correlates of 1-year prospective outcome in bipolar disorder: Results from the Stanley foundation bipolar network
Nolen, W. A., Luckenbaugh, D. A., Altshuler, L. L., Suppes, T., McElroy, S. L., & Post, R. M. (2004). Correlates of 1-year prospective outcome in bipolar disorder: Results from the Stanley foundation bipolar network. AMERICAN JOURNAL OF PSYCHIATRY, 161(8), 1447-1454.

Response to clozapine of rapid cycling versus non-cycling patients with a history of mania
Suppes, T., Ozcan, M. E., & Carmody, T. (2004). Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. BIPOLAR DISORDERS, 6(4), 329-332.

Clinical results for patients with major depressive disorder in the Texas medication algorithm project
Trivedi, M. H., Rush, A. J., Crismon, M. L., Kashner, T. M., Toprac, M. G., & Shon, S. P. (2004). Clinical results for patients with major depressive disorder in the Texas medication algorithm project. ARCHIVES OF GENERAL PSYCHIATRY, 61(7), 669-680.

Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder
Dennehy, E. B., Suppes, T., Crismon, M. L., Toprac, M., Carmody, T. J., & Rush, A. J. (2004). Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder. PSYCHIATRY RESEARCH, 127(1-2), 137-145.

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study
Sachs, G., Chengappa, K. Nr., Suppes, T., MULLEN, J. A., Brecher, M., & Sweitzer, D. E. (2004). Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. BIPOLAR DISORDERS, 6(3), 213-223.

Use of quetiapine in bipolar disorder: a case series with prospective evaluation
Suppes, T., McElroy, S. L., Keck, P. E., Altshuler, L., Frye, M. A., & Post, R. M. (2004). Use of quetiapine in bipolar disorder: a case series with prospective evaluation. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 19(3), 173-174.

Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder
Dennehy, E. B., Suppes, T., Rush, A. J., Crismon, M. L., Witte, B., & Webster, J. (2004). Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder. JOURNAL OF PSYCHIATRIC RESEARCH, 38(3), 285-294.

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone
Tohen, M., Chengappa, K. Nr., Suppes, T., Baker, R. W., Zarate, C. A., & Calabrese, J. R. (2004). Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. BRITISH JOURNAL OF PSYCHIATRY, 184, 337-345.

Management of bipolar disorder during pregnancy and the postpartum period
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., & Altshuler, L. (2004). Management of bipolar disorder during pregnancy and the postpartum period. AMERICAN JOURNAL OF PSYCHIATRY, 161(4), 608-620.

Self-reported participation in nonpharmacologic treatments for bipolar disorder
Dennehy, E. B., GONZALEZ, R., & Suppes, T. (2004). Self-reported participation in nonpharmacologic treatments for bipolar disorder. JOURNAL OF CLINICAL PSYCHIATRY, 65(2), 278-278.

A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression
McElroy, S. L., Zarate, C. A., Cookson, J., Suppes, T., Huffman, R. F., & Ascher, J. (2004). A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. JOURNAL OF CLINICAL PSYCHIATRY, 65(2), 204-210.

Treatment of rapid-cycling bipolar disorder
Post, R. M., Chang, K. D., Suppes, T., & Ginsberg, D. L. (2004). Treatment of rapid-cycling bipolar disorder. CNS SPECTRUMS, 9(2), 1-10.

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
Trivedi, M. H., Rush, A. J., Ibrahim, H. M., Carmody, T. J., Biggs, M. M., & Kashner, T. M. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. PSYCHOLOGICAL MEDICINE, 34(1), 73-82.

The Texas Medication Algorithm Project: Clinical results for schizophrenia
Miller, A. L., Crismon, M. L., Rush, A. J., Chiles, J., Kashner, T. M., & Shon, S. (2004). The Texas Medication Algorithm Project: Clinical results for schizophrenia. SCHIZOPHRENIA BULLETIN, 30(3), 627-647.

A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network
Post, R. M., Leverich, G. S., Nolen, W. A., Kupka, R. W., Altshuler, L. L., & Walden, J. (2003). A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. BIPOLAR DISORDERS, 5(6), 396-406.

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I)
Post, R. M., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., & Walden, J. (2003). An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). BIPOLAR DISORDERS, 5(5), 310-319.

Psychosis in bipolar disorder: Phenomenology and impact on morbidity and course of illness
Keck, P. E., McElroy, S. L., Havens, J. R., Altshuler, L. L., Nolen, W. A., & Post, R. M. (2003). Psychosis in bipolar disorder: Phenomenology and impact on morbidity and course of illness. COMPREHENSIVE PSYCHIATRY, 44(4), 263-269.

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., & Post, R. (2003). Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. AMERICAN JOURNAL OF PSYCHIATRY, 160(7), 1252-1262.

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study
Tohen, M., Ketter, T. A., Zarate, C. A., Suppes, T., Frye, M., & Baker, R. W. (2003). Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study. AMERICAN JOURNAL OF PSYCHIATRY, 160(7), 1263-1271.

Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method
Post, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., & Nolen, W. A. (2003). Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method. JOURNAL OF CLINICAL PSYCHIATRY, 64(6), 680-690.

How rare is bipolar disorder not otherwise specified?
Ozcan, M. E., Shiekh, M., & Suppes, T. (2003). How rare is bipolar disorder not otherwise specified?. BIPOLAR DISORDERS, 5(3), 226-227.

Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., Keck, P. E., & Post, R. M. (2003). Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. JOURNAL OF CLINICAL PSYCHIATRY, 64(5), 506-515.

Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder
Frye, M. A., Altshuler, L. L., McElroy, S. L., Suppes, T., Keck, P. E., & Post, R. M. (2003). Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. AMERICAN JOURNAL OF PSYCHIATRY, 160(5), 883-889.

The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting
Dennehy, E. B., Doyle, K., & Suppes, T. (2003). The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 18(3), 143-145.

Texas Medication Algorithm Project, Phase 3 (TMAP-3): Clinical results for patients with a history of mania
Suppes, T., Rush, A. J., Dennehy, E. B., Crismon, M. L., Kashner, T. M., & Shon, S. P. (2003). Texas Medication Algorithm Project, Phase 3 (TMAP-3): Clinical results for patients with a history of mania. JOURNAL OF CLINICAL PSYCHIATRY, 64(4), 370-382.

Texas Medication Algorithm Project, Phase 3 (TMAP-3): Rationale and study design
Rush, A. J., Crismon, M. L., Kashner, T. M., Toprac, M. G., Carmody, T. J., & Altshuler, K. Z. (2003). Texas Medication Algorithm Project, Phase 3 (TMAP-3): Rationale and study design. JOURNAL OF CLINICAL PSYCHIATRY, 64(4), 357-369.

Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project
Brown, E. S., Rush, A. J., Biggs, M. M., Shores-Wilson, K., Carmody, T. J., & Suppes, T. (2003). Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project. PSYCHIATRY RESEARCH, 117(2), 167-175.

Catching up on health outcomes: The Texas Medication Algorithm Project
Kashner, T. M., Carmody, T. J., Suppes, T., Rush, A. J., Crismon, M. L., & Trivedi, M. (2003). Catching up on health outcomes: The Texas Medication Algorithm Project. HEALTH SERVICES RESEARCH, 38(1), 311-331.

High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder
Breunis, M. N., Kupka, R. W., Nolen, W. A., Suppes, T., Denicoff, K. D., & Drexhage, H. A. (2003). High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. BIOLOGICAL PSYCHIATRY, 53(2), 157-165.

Presentations of depression in bipolar illness
Post, R. A., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., & Walden, J. (2002). Presentations of depression in bipolar illness. CLINICAL NEUROSCIENCE RESEARCH, 2(3-4), 142-157.

Review of the use of topiramate for treatment of bipolar disorders
Suppes, T. (2002). Review of the use of topiramate for treatment of bipolar disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 22(6), 599-609.

Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management
Calabrese, J. R., Sullivan, J. R., Bowden, C. L., Suppes, T., Goldberg, J. F., & Kusumakar, V. (2002). Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management. JOURNAL OF CLINICAL PSYCHIATRY, 63(11), 1012-1019.

Tiagabine in treatment refractory bipolar disorder: a clinical case series
Suppes, T., Chisholm, K. A., Dhavale, D., Frye, M. A., Atshuler, L. L., & Post, R. M. (2002). Tiagabine in treatment refractory bipolar disorder: a clinical case series. BIPOLAR DISORDERS, 4(5), 283-289.

Developing novel treatments for mood disorders: Accelerating discovery
Tamminga, C. A., Nemeroff, C. B., Blakely, R. D., Brady, L., Carter, C. S., & Suppes, T. (2002). Developing novel treatments for mood disorders: Accelerating discovery. BIOLOGICAL PSYCHIATRY, 52(6), 589-609.

Assessment of beliefs in the effectiveness of acupuncture for treatment of psychiatric symptoms
Dennehy, E. B., Webb, A., & Suppes, T. (2002). Assessment of beliefs in the effectiveness of acupuncture for treatment of psychiatric symptoms. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 8(4), 421-425.

Olanzapine versus divalproex in the treatment of acute mania
Tohen, M., Baker, R. W., Altshuler, L. L., Zarate, C. A., Suppes, T., & Tollefson, G. A. (2002). Olanzapine versus divalproex in the treatment of acute mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(6), 1011-1017.

Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000
Suppes, T., Dennehy, E. B., Swann, A. C., Bowden, C. L., Calabrese, J. R., & Shon, S. R. (2002). Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000. JOURNAL OF CLINICAL PSYCHIATRY, 63(4), 288-299.

Correlates of overweight and obesity in 644 patients with bipolar disorder
McElroy, S. L., Frye, M. A., Suppes, T., Dhavale, D., Keck, P. E., & Post, R. M. (2002). Correlates of overweight and obesity in 644 patients with bipolar disorder. JOURNAL OF CLINICAL PSYCHIATRY, 63(3), 207-213.

High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure
Kupka, R. W., Nolen, W. A., Post, R. M., McElroy, S. L., Altshuler, L. L., & Drexhage, H. A. (2002). High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure. BIOLOGICAL PSYCHIATRY, 51(4), 305-311.

Early physical and sexual abuse associated with an adverse course of bipolar illness
Leverich, G. S., McElroy, S. L., Suppes, T., Keck, P. E., Denicoff, K. D., & Post, R. M. (2002). Early physical and sexual abuse associated with an adverse course of bipolar illness. BIOLOGICAL PSYCHIATRY, 51(4), 288-297.

Mood changes during prednisone bursts in outpatients with asthma
Brown, E. S., Suppes, T., Khan, D. A., & Carmody, T. J. (2002). Mood changes during prednisone bursts in outpatients with asthma. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 22(1), 55-61.

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy
Tohen, M., Chengappa, K. Nr., Suppes, T., Zarate, C. A., Calabrese, J. R., & Breier, A. (2002). Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. ARCHIVES OF GENERAL PSYCHIATRY, 59(1), 62-69.

Evidence-based long-term treatment of bipolar II disorder
Suppes, T., & Dennehy, E. B. (2002). Evidence-based long-term treatment of bipolar II disorder. JOURNAL OF CLINICAL PSYCHIATRY, 63, 29-33.

The Stanley Foundation Bipolar Treatment Outcome Network II. Demographics and illness characteristics of the first 261 patients
Suppes, T., Leverich, G. S., Keck, P. E., Nolen, W. A., Denicoff, K. D., & Post, R. M. (2001). The Stanley Foundation Bipolar Treatment Outcome Network II. Demographics and illness characteristics of the first 261 patients. JOURNAL OF AFFECTIVE DISORDERS, 67(1-3), 45-59.

The Stanley Foundation Bipolar Treatment Outcome Network I. Longitudinal methodology
Leverich, G. S., Nolen, W. A., Rush, A. J., McElroy, S. L., Keck, P. E., & Post, R. M. (2001). The Stanley Foundation Bipolar Treatment Outcome Network I. Longitudinal methodology. JOURNAL OF AFFECTIVE DISORDERS, 67(1-3), 33-44.

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers
Post, R. M., Altshuler, L. L., Frye, M. A., Suppes, T., Rush, A. J., & Nolen, W. A. (2001). Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. BIPOLAR DISORDERS, 3(5), 259-265.

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?
Brown, E. S., Suppes, T., Adinoff, B., & Thomas, N. R. (2001). Drug abuse and bipolar disorder: comorbidity or misdiagnosis?. JOURNAL OF AFFECTIVE DISORDERS, 65(2), 105-115.

The Stanley Foundation Bipolar Network. I. Rationale and methods.
Post, R. M., Nolen, W. A., Kupka, R. W., Denicoff, K. D., Leverich, G. S., & Walden, J. (2001). The Stanley Foundation Bipolar Network. I. Rationale and methods. British journal of psychiatry. Supplement, 41, s169-76.

The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments.
Kupka, R. W., Nolen, W. A., Altshuler, L. L., Denicoff, K. D., Frye, M. A., & Post, R. M. (2001). The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments. British journal of psychiatry. Supplement, 41, s177-83.

Texas Medication Algorithm Project: Development and feasibility testing of a treatment algorithm for patients with bipolar disorder
Suppes, T., Swann, A. C., Dennehy, E. B., Habermacher, E. D., Mason, M., & Altshuler, K. Z. (2001). Texas Medication Algorithm Project: Development and feasibility testing of a treatment algorithm for patients with bipolar disorder. JOURNAL OF CLINICAL PSYCHIATRY, 62(6), 439-447.

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder
McElroy, S. L., Altshuler, L. L., Suppes, T., Keck, P. E., Frye, M. A., & Post, R. M. (2001). Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. AMERICAN JOURNAL OF PSYCHIATRY, 158(3), 420-426.

Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia
Glick, I. D., Suppes, T., Debattista, C., Hu, R. J., & Marder, S. (2001). Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia. ANNALS OF INTERNAL MEDICINE, 134(1), 47-60.

Bipolar rapid cycling: Focus on depression as its hallmark
Calabrese, J. R., Shelton, M. D., Bowden, C. L., Rapport, D. J., Suppes, T., & Caban, S. J. (2001). Bipolar rapid cycling: Focus on depression as its hallmark. JOURNAL OF CLINICAL PSYCHIATRY, 62, 34-41.

A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., & Monaghan, E. T. (2000). A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. JOURNAL OF CLINICAL PSYCHIATRY, 61(11), 841-850.

Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM (TM)-p) for longitudinal assessment of bipolar illness
Denicoff, K. D., Leverich, G. S., Nolen, W. A., Rush, A. J., McElroy, S. L., & Post, R. M. (2000). Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM (TM)-p) for longitudinal assessment of bipolar illness. PSYCHOLOGICAL MEDICINE, 30(6), 1391-1397.

Efficacy of divalproex therapy for schizoaffective disorder
Bogan, A. M., Brown, E. S., & Suppes, T. (2000). Efficacy of divalproex therapy for schizoaffective disorder. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 20(5), 520-522.

The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and noneffective psychosis
Tohen, M., Strakowski, S. M., Zarate, C., Hennen, J., Stoll, A. L., & BALDESSARINI, R. J. (2000). The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and noneffective psychosis. BIOLOGICAL PSYCHIATRY, 48(6), 467-476.

Methodological issues in developing new acute treatments for patients with bipolar illness
Rush, A. J., Post, R. M., Nolen, W. A., Keck, P. E., Suppes, T., & McElroy, S. L. (2000). Methodological issues in developing new acute treatments for patients with bipolar illness. BIOLOGICAL PSYCHIATRY, 48(6), 615-624.

Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders; a summary of two previous studies
Kowatch, R. A., Carmody, T. J., Suppes, T., Hume, J. H., Kromelis, M., & Weinberg, W. A. (2000). Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders; a summary of two previous studies. ACTA NEUROPSYCHIATRICA, 12(3), 145-149.

A review of randomized, controlled clinical trials in acute mania
Keck, P. E., Mendlwicz, J., Calabrese, J. R., Fawcett, J., Suppes, T., & Carbonell, C. (2000). A review of randomized, controlled clinical trials in acute mania. JOURNAL OF AFFECTIVE DISORDERS, 59, S31-S37.

Open-label adjunctive topiramate in the treatment of bipolar disorders
McElroy, S. L., Suppes, T., Keck, P. E., Frye, M. A., Denicoff, K. D., & Post, R. M. (2000). Open-label adjunctive topiramate in the treatment of bipolar disorders. BIOLOGICAL PSYCHIATRY, 47(12), 1025-1033.

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder
Kowatch, R. A., Suppes, T., Carmody, T. J., Bucci, J. P., Hume, J. H., & Rush, A. J. (2000). Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 39(6), 713-720.

Comparison of the Internal State Scale to clinician-administered scales in asthma patients receiving corticosteroid therapy
Brown, E. S., Bauer, M. S., Suppes, T., Khan, D. A., & Carmody, T. (2000). Comparison of the Internal State Scale to clinician-administered scales in asthma patients receiving corticosteroid therapy. GENERAL HOSPITAL PSYCHIATRY, 22(3), 180-183.

Forum. What are the mental health complications of steroid therapy?
Brown, E. S., & Suppes, T. (2000). Forum. What are the mental health complications of steroid therapy?. The Harvard mental health letter / from Harvard Medical School, 16(8), 8-?.

Switching outpatients between atypical antipsychotics
Bogan, A. M., Shellhorn, E., Brown, E. S., Mcdanald, C., & Suppes, T. (2000). Switching outpatients between atypical antipsychotics. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 24(2), 351-355.

Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features
Tohen, M., Hennen, J., Zarate, C. M., BALDESSARINI, R. J., Strakowski, S. M., & Cohen, B. M. (2000). Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. AMERICAN JOURNAL OF PSYCHIATRY, 157(2), 220-228.

The longitudinal course of bipolar disorder
Suppes, T., Dennehy, E. B., & Gibbons, E. W. (2000). The longitudinal course of bipolar disorder. JOURNAL OF CLINICAL PSYCHIATRY, 61, 23-30.

Treating bipolar illness: Focus on treatment algorithms and management of the sleep-wake cycle
Leibenluft, E., & Suppes, T. (1999). Treating bipolar illness: Focus on treatment algorithms and management of the sleep-wake cycle. AMERICAN JOURNAL OF PSYCHIATRY, 156(12), 1976-1981.

Clozapine associated with decreased suicidality in bipolar disorder: a case report.
Vangala, V. R., Brown, E. S., & Suppes, T. (1999). Clozapine associated with decreased suicidality in bipolar disorder: a case report. Bipolar disorders, 1(2), 123-124.

Gabapentin in the acute treatment of refractory bipolar disorder.
Altshuler, L. L., Keck, P. E., McElroy, S. L., Suppes, T., Brown, E. S., & Post, R. (1999). Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar disorders, 1(1), 61-65.

Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania
Suppes, T., Webb, A., Paul, B., Carmody, T., Kraemer, H., & Rush, A. J. (1999). Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. AMERICAN JOURNAL OF PSYCHIATRY, 156(8), 1164-1169.

Lamotrigine in the treatment of bipolar depression
Bowden, C. L., Mitchell, P., & Suppes, T. (1999). Lamotrigine in the treatment of bipolar depression. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 9, S113-S117.

Treatment of corticosteroid-induced mood changes with olanzapine
Brown, E. S., Khan, D. A., & Suppes, T. (1999). Treatment of corticosteroid-induced mood changes with olanzapine. AMERICAN JOURNAL OF PSYCHIATRY, 156(6), 968-968.

Medication treatment for the severely and persistently mentally ill: The Texas Medication Algorithm Project
Rush, A. J., Rago, W. V., Crismon, M. L., Toprac, M. G., Shon, S. P., & Altshuler, K. Z. (1999). Medication treatment for the severely and persistently mentally ill: The Texas Medication Algorithm Project. JOURNAL OF CLINICAL PSYCHIATRY, 60(5), 284-291.

Lamotrigine for the treatment of bipolar disorder: a clinical case series
Suppes, T., Brown, E. S., McElroy, S. L., Keck, P. E., Nolen, W., & Post, R. M. (1999). Lamotrigine for the treatment of bipolar disorder: a clinical case series. JOURNAL OF AFFECTIVE DISORDERS, 53(1), 95-98.

Measuring use of outpatient care among mentally ill individuals: a comparison of self reports and provider records
Kashner, T. M., Suppes, T., Rush, A. J., & Altshuler, K. Z. (1999). Measuring use of outpatient care among mentally ill individuals: a comparison of self reports and provider records. EVALUATION AND PROGRAM PLANNING, 22(1), 31-39.

Mental health care from the public perspective: The Texas Medication Algorithm Project
Shon, S. P., Crismon, M. L., Toprac, M. G., Trivedi, M., Miller, A. L., & Rush, A. J. (1999). Mental health care from the public perspective: The Texas Medication Algorithm Project. JOURNAL OF CLINICAL PSYCHIATRY, 60, 16-21.

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania
Knoll, J., Stegman, K., & Suppes, T. (1998). Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. JOURNAL OF AFFECTIVE DISORDERS, 49(3), 229-233.

Olanzapine in treatment-resistant bipolar disorder
McElroy, S. L., Frye, M., Denicoff, K., Altshuler, L., Nolen, W., & Post, R. M. (1998). Olanzapine in treatment-resistant bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, 49(2), 119-122.

What are the new treatments for bipolar disorder?
Rush, A. J., & Suppes, T. (1998). What are the new treatments for bipolar disorder?. The Harvard mental health letter / from Harvard Medical School, 14(11), 8-?.

Gastrointestinal side-effects after switch to generic valproic acid
Brown, E. S., Shellhorn, E., & Suppes, T. (1998). Gastrointestinal side-effects after switch to generic valproic acid. PHARMACOPSYCHIATRY, 31(3), 114-114.

Treatment algorithm use to optimize management of symptomatic patients with a history of mania
Suppes, T., Rush, A. J., Kraemer, H. C., & Webb, A. (1998). Treatment algorithm use to optimize management of symptomatic patients with a history of mania. JOURNAL OF CLINICAL PSYCHIATRY, 59(2), 89-96.

A new algorithm for treating schizophrenia
Pearsall, R., Glick, I. D., Pickard, D., Suppes, T., Tauscher, J., & Jobson, K. O. (1998). A new algorithm for treating schizophrenia. PSYCHOPHARMACOLOGY BULLETIN, 34(3), 349-353.

Mood symptoms during corticosteroid therapy: A review
Brown, E. S., & Suppes, T. (1998). Mood symptoms during corticosteroid therapy: A review. HARVARD REVIEW OF PSYCHIATRY, 5(5), 239-246.

The atypical antipsychotic sertindole: A case series
Lee, A. M., Knoll, J. L., & Suppes, T. (1997). The atypical antipsychotic sertindole: A case series. JOURNAL OF CLINICAL PSYCHIATRY, 58(9), 410-416.

Gabapentin for treatment of bipolar and schizoaffective disorders
Bennett, J., GOLDMAN, W. T., & Suppes, T. (1997). Gabapentin for treatment of bipolar and schizoaffective disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 17(2), 141-142.

Special treatment issues: Maintaining and discontinuing psychotropic medications
Suppes, T., BALDESSARINI, R. J., Motohashi, N., Tondo, L., & Viguera, A. C. (1997). Special treatment issues: Maintaining and discontinuing psychotropic medications. MOOD DISORDERS, 25, 235-254.

Is postictal electrical silence a predictor of response to electroconvulsive therapy?
Suppes, T., Webb, A., Carmody, T., Gordon, E., GUTIERREZESTEINOU, R., & Pope, H. G. (1996). Is postictal electrical silence a predictor of response to electroconvulsive therapy?. JOURNAL OF AFFECTIVE DISORDERS, 41(1), 55-58.

Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders
BALDESSARINI, R. J., Tondo, L., Faedda, G. L., Suppes, T. R., Floris, G., & Rudas, N. (1996). Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. JOURNAL OF CLINICAL PSYCHIATRY, 57(10), 441-448.

Medication optimization during clozapine treatment
Suppes, T., & Rush, A. J. (1996). Medication optimization during clozapine treatment. JOURNAL OF CLINICAL PSYCHIATRY, 57(7), 307-308.

Capgras' and Fregoli's syndromes in one family
Brown, E. S., Thompson, R., & Suppes, T. (1996). Capgras' and Fregoli's syndromes in one family. JOURNAL OF CLINICAL PSYCHIATRY, 57(3), 137-138.

Lithium Withdrawal in Bipolar Disorder: Implications for Clinical Practice and Experimental Therapeutics Research.
Baldessarini, R. J., Suppes, T., & Tondo, L. (1996). Lithium Withdrawal in Bipolar Disorder: Implications for Clinical Practice and Experimental Therapeutics Research. American journal of therapeutics, 3(7), 492-496.

PEDIATRIC-ONSET BIPOLAR DISORDER - A NEGLECTED CLINICAL AND PUBLIC-HEALTH PROBLEM
Faedda, G. L., BALDESSARINI, R. J., Suppes, T., Tondo, L., Becker, I., & Lipschitz, D. S. (1995). PEDIATRIC-ONSET BIPOLAR DISORDER - A NEGLECTED CLINICAL AND PUBLIC-HEALTH PROBLEM. HARVARD REVIEW OF PSYCHIATRY, 3(4), 171-195.

A CLINICALLY SIGNIFICANT INTERACTION BETWEEN CLOZAPINE AND VALPROATE
COSTELLO, L. E., & Suppes, T. (1995). A CLINICALLY SIGNIFICANT INTERACTION BETWEEN CLOZAPINE AND VALPROATE. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 15(2), 139-141.

Algorithms for the treatment of bipolar manic-depressive illness.
Suppes, T., Calabrese, J. R., Mitchell, P. B., Pazzaglia, P. J., Potter, W. Z., & Zarin, D. A. (1995). Algorithms for the treatment of bipolar manic-depressive illness. Psychopharmacology bulletin, 31(3), 469-474.

NEUROLOGIC FACTORS PREDICT A FAVORABLE VALPROATE RESPONSE IN BIPOLAR AND SCHIZOAFFECTIVE DISORDERS
Stoll, A. L., Banov, M., KOLBRENER, M., Mayer, P. V., Tohen, M., & Cohen, B. M. (1994). NEUROLOGIC FACTORS PREDICT A FAVORABLE VALPROATE RESPONSE IN BIPOLAR AND SCHIZOAFFECTIVE DISORDERS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 14(5), 311-313.

CLOZAPINE TREATMENT OF NONPSYCHOTIC RAPID-CYCLING BIPOLAR DISORDER - A REPORT OF 3 CASES
Suppes, T., Phillips, K. A., & JUDD, C. R. (1994). CLOZAPINE TREATMENT OF NONPSYCHOTIC RAPID-CYCLING BIPOLAR DISORDER - A REPORT OF 3 CASES. BIOLOGICAL PSYCHIATRY, 36(5), 338-340.

STEREOTYPICAL CHANGES IN THE PATTERN AND DURATION OF LONG-TERM POTENTIATION EXPRESSED AT POSTNATAL DAYS 11 AND 15 IN THE RAT HIPPOCAMPUS
Jackson, P. S., Suppes, T., & Harris, K. M. (1993). STEREOTYPICAL CHANGES IN THE PATTERN AND DURATION OF LONG-TERM POTENTIATION EXPRESSED AT POSTNATAL DAYS 11 AND 15 IN THE RAT HIPPOCAMPUS. JOURNAL OF NEUROPHYSIOLOGY, 70(4), 1412-1419.

DISCONTINUATION OF MAINTENANCE TREATMENT IN BIPOLAR DISORDER - RISKS AND IMPLICATIONS
Suppes, T., BALDESSARINI, R. J., Faedda, G. L., Tondo, L., & Tohen, M. (1993). DISCONTINUATION OF MAINTENANCE TREATMENT IN BIPOLAR DISORDER - RISKS AND IMPLICATIONS. HARVARD REVIEW OF PSYCHIATRY, 1(3), 131-144.

OUTCOME AFTER RAPID VS GRADUAL DISCONTINUATION OF LITHIUM TREATMENT IN BIPOLAR DISORDERS
Faedda, G. L., Tondo, L., BALDESSARINI, R. J., Suppes, T., & Tohen, M. (1993). OUTCOME AFTER RAPID VS GRADUAL DISCONTINUATION OF LITHIUM TREATMENT IN BIPOLAR DISORDERS. ARCHIVES OF GENERAL PSYCHIATRY, 50(6), 448-455.

Combined Clozapine and Electroconvulsive Therapy.
Frankenburg, F. R., Suppes, T., & McLean, P. E. (1993). Combined Clozapine and Electroconvulsive Therapy. Convulsive therapy, 9(3), 176-180.

CLOZAPINE IN THE TREATMENT OF DYSPHORIC MANIA
Suppes, T., McElroy, S. L., Gilbert, J., Dessain, E. C., & Cole, J. O. (1992). CLOZAPINE IN THE TREATMENT OF DYSPHORIC MANIA. BIOLOGICAL PSYCHIATRY, 32(3), 270-280.

RISK OF RECURRENCE FOLLOWING DISCONTINUATION OF LITHIUM TREATMENT IN BIPOLAR DISORDER
Suppes, T., BALDESSARINI, R. J., Faedda, G. L., & Tohen, M. (1991). RISK OF RECURRENCE FOLLOWING DISCONTINUATION OF LITHIUM TREATMENT IN BIPOLAR DISORDER. ARCHIVES OF GENERAL PSYCHIATRY, 48(12), 1082-1088.

CELLULAR AND SYNAPTIC PHYSIOLOGY AND EPILEPTOGENESIS OF DEVELOPING RAT NEOCORTICAL NEURONS INVITRO
Kriegstein, A. R., Suppes, T., & Prince, D. A. (1987). CELLULAR AND SYNAPTIC PHYSIOLOGY AND EPILEPTOGENESIS OF DEVELOPING RAT NEOCORTICAL NEURONS INVITRO. DEVELOPMENTAL BRAIN RESEARCH, 34(2), 161-171.

Cellular and synaptic physiology and epileptogenesis of developing rat neocortical neurons in vitro.
Kriegstein, A. R., Suppes, T., & Prince, D. A. (1987). Cellular and synaptic physiology and epileptogenesis of developing rat neocortical neurons in vitro. Brain research, 431(2), 161-171.

SENSITIVITY OF NEURONAL DOPAMINE RESPONSE IN THE SUBSTANTIA-NIGRA AND VENTRAL TEGMENTUM TO CLOZAPINE, METOCLOPRAMIDE AND SCH 23390
Suppes, T., & Pinnock, R. D. (1987). SENSITIVITY OF NEURONAL DOPAMINE RESPONSE IN THE SUBSTANTIA-NIGRA AND VENTRAL TEGMENTUM TO CLOZAPINE, METOCLOPRAMIDE AND SCH 23390. NEUROPHARMACOLOGY, 26(4), 331-337.

THE INFLUENCE OF DOPAMINE ON EPILEPTIFORM BURST ACTIVITY IN HIPPOCAMPAL PYRAMIDAL NEURONS
Suppes, T., Kriegstein, A. R., & Prince, D. A. (1985). THE INFLUENCE OF DOPAMINE ON EPILEPTIFORM BURST ACTIVITY IN HIPPOCAMPAL PYRAMIDAL NEURONS. BRAIN RESEARCH, 326(2), 273-280.

A LATE SLOW DEPOLARIZATION UNMASKED IN THE PRESENCE OF TETRAETHYLAMMONIUM IN NEONATAL RAT SYMPATHETIC NEURONS INVITRO
Suppes, T. (1984). A LATE SLOW DEPOLARIZATION UNMASKED IN THE PRESENCE OF TETRAETHYLAMMONIUM IN NEONATAL RAT SYMPATHETIC NEURONS INVITRO. BRAIN RESEARCH, 293(2), 269-278.

CHOLINERGIC ENHANCEMENT OF PENICILLIN-INDUCED EPILEPTIFORM DISCHARGES IN PYRAMIDAL NEURONS OF THE GUINEA-PIG HIPPOCAMPUS
Kriegstein, A. R., Suppes, T., & Prince, D. A. (1983). CHOLINERGIC ENHANCEMENT OF PENICILLIN-INDUCED EPILEPTIFORM DISCHARGES IN PYRAMIDAL NEURONS OF THE GUINEA-PIG HIPPOCAMPUS. BRAIN RESEARCH, 266(1), 137-142.